FARALIMOMAB
UNII 8MK3PL8DNZ

Substance Identification & Data

This profile provides standardized clinical and technical data for Faralimomab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8MK3PL8DNZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 167816-91-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8MK3PL8DNZ
CAS Registry Number
167816-91-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
FARALIMOMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C188538
National Cancer Institute reference terminology for clinical and research data.
INN ID
7496
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Faralimomab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FARALIMOMAB

Common Names & Synonyms

FARALIMOMAB [INN]
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERFERON TYPE I RECEPTOR) (MOUSE MONOCLONAL 64G12 G1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL 64G12 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERFERON TYPE I RECEPTOR) (MOUSE MONOCLONAL 64G12 G1-CHAIN), DISULPHIDE WITH MOUSE MONOCLONAL 64G12 LIGHT CHAIN, DIMER

Technical Codes

64G12

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus